etoposide has been researched along with Thrombopenia in 246 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (11.38) | 18.7374 |
1990's | 113 (45.93) | 18.2507 |
2000's | 68 (27.64) | 29.6817 |
2010's | 31 (12.60) | 24.3611 |
2020's | 6 (2.44) | 2.80 |
Authors | Studies |
---|---|
Bullock, TN; Carducci, MA; Gentzler, RD; Hanley, M; Horton, B; Kim, K; Mock, J; Park, KS; Phelps, MA; Piekarz, R; Rhee, JC; Rudek, MA; Rudin, CM; Villaruz, LC | 1 |
Aboulafia, D; Ambinder, RF; Baiocchi, R; Capoferri, AA; Cesarman, E; Chadburn, A; Durand, CM; Kaplan, L; Lee, JY; Mitsuyasu, R; Moore, PC; Noy, A; Ramos, JC; Ratner, L; Reid, EG; Rubinstein, PG; Siegel, ER; Sparano, JA | 1 |
Bartolini, S; Brandes, AA; Franceschi, E; Mascarin, M; Minichillo, S; Mura, A; Tomasello, C; Tosoni, A | 1 |
Gruner, SE; Hernandez, JA; Rainusso, N | 1 |
Ddungu, H; Mulumba, Y; Okello, CD; Omoding, A; Orem, J | 1 |
Kheifetz, Y; Scholz, M | 1 |
Han, D; Li, S; Ren, X; Shang, W; Sun, L; Wang, G; Xu, L | 1 |
Claret, L; Copeland, AR; Fanale, MA; Fayad, LE; Feng, L; Fowler, N; Hagemeister, FB; Hu, B; Nastoupil, LJ; Neelapu, S; Nieto, Y; Oki, Y; Rodriguez, MA; Romaguera, J; Samaniego, F; Turturro, F; Westin, JR; Younes, A | 1 |
Awataguchi, T; Hirakawa, H; Kadota, R; Kiba, T; Noguchi, N; Ota, N; Otomo, C; Saito, M; Saito, Y; Sakaguchi, M; Sato, M; Shoji, F; Suzuki, T; Takahashi, T; Watanabe, Y | 1 |
Gomyo, H; Hiramatsu, Y; Maeda, Y; Masaki, Y; Masunari, T; Matsuo, K; Nakamura, S; Nawa, Y; Nishimori, H; Ohshima, K; Sunami, K; Takahashi, T; Tanimoto, M; Uno, M; Yamane, H; Yano, T; Yoshida, I; Yoshino, T | 1 |
Fukui, T; Igawa, S; Katagiri, M; Kubota, M; Kurahayashi, S; Mitsufuji, H; Naoki, K; Nishinarita, N; Okuma, Y; Ono, T; Ozawa, T; Sasaki, J; Shirasawa, M; Sone, H; Sugimoto, A; Sugita, K | 1 |
Anzai, M; Goto, N; Ishizuka, T; Kadowaki, M; Kodawara, T; Morikawa, M; Nakamura, T; Negoro, Y; Suehiro, Y; Tsukamoto, H; Umeda, Y; Watanabe, K; Yamashita, S; Yano, R; Yoshimura, M | 1 |
Liu, W; Liu, X; Song, Y; Wu, M; Xie, Y; Yang, M; Zheng, W; Zhu, J | 1 |
Gálvez, A; Hancock, CL | 1 |
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
Barr, PM; Caimi, PF; Carson, KR; Evens, AM; Gordon, LI; Gregory, SA; Helenowski, I; Islam, N; Jovanovic, B; Kolesar, J; Nabhan, C | 1 |
Advani, R; Ansell, SM; Bartlett, NL; Belada, D; Coiffier, B; Drachman, JG; Fayad, L; Forero-Torres, A; Kuliczkowski, K; Ng, E; Stuart, R | 1 |
Aggarwal, C; Belani, CP; Dahlberg, SE; Dowell, J; Gerber, DE; Hann, CL; Khan, SA; Moss, RA; Owonikoko, TK; Ramalingam, SS | 1 |
Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y | 1 |
Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ | 1 |
Cheng, Y; Cui, HX; Li, ZL; Ma, LX; Sun, SY; Yang, CL | 1 |
Chow, L; Eckhardt, SG; Gore, L; Lieu, C; Morrow, M; O'Bryant, CL; Pierson, AS; Tran, ZV; Wright, JJ | 1 |
Han, XH; He, XH; Li, B; Liu, P; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhou, SY | 1 |
Cui, XZ; Hao, XS; Li, LF; Li, W; Liu, PF; Liu, XM; Qiu, LH; Wang, HQ; Zhang, HL | 1 |
Beaven, AW; Chao, N; Gabriel, DA; Garcia, RA; Gockerman, JP; Moore, DT; Rizzieri, DA; Serody, JS; Shea, TC | 1 |
Lou, F; Pan, HM; Zhu, YH | 1 |
Guan, ZZ; Lin, H; Ling, JY; Luo, WB; Peng, RJ; Sun, XF; Xia, Y; Xiang, XJ; Zhen, ZJ; Zheng, L | 1 |
Boddy, AV; Cole, M; Ellershaw, C; Errington, J; Gerrard, M; Pearson, AD; Veal, GJ; Whyman, G | 1 |
Bessho, M; Hagiwara, Y; Kohri, M; Niitsu, N; Okamoto, M; Takahashi, N; Tanae, K | 1 |
Bao, Y; Chen, J; Chen, M; Cheng, Y; He, H; Hu, X; Li, K; Liang, Y; Liu, Y; Sun, Z; Wang, F; Wang, W; Wang, Y; Zhang, L; Zhang, Y; Zhao, H; Zhuang, T | 1 |
Billaud, EM; Bobin-Dubigeon, C; Boisdron-Celle, M; Boyer, JC; Chatelut, E; Concordet, D; Durdux, C; Etienne-Grimaldi, MC; Evrard, A; Floquet, A; Gladieff, L; Laffont, CM; Lafont, T; Lansiaux, A; Le Guellec, C; Mazières, J; Mousseau, M; Ollivier, F; Pinguet, F; Schmitt, A | 1 |
Bazan, F; Chaigneau, L; Demarchi, M; Dobi, E; Ivanaj, A; Kalbacher, E; Maurina, T; Montange, D; Nguyen, T; Pivot, X; Royer, B; Thiery-Vuillemin, A; Villanueva, C | 1 |
Ashcroft, L; Blackhall, F; Califano, R; Colaco, R; Faivre-Finn, C; Lorigan, P; Sheikh, H; Taylor, P; Thatcher, N | 1 |
Cai, Q; Huang, H; Jiang, W; Lin, X; Lin, Z; Xia, Z | 1 |
Blagden, S; Gabra, H; Graham, J; Sharma, R | 1 |
Aricò, M; Berglöf, E; Beutel, K; Henter, JI; Horne, A; Janka, G; Lehmberg, K; Onelöv, E; Sieni, E; Silfverberg, T; Trottestam, H | 1 |
Hwang, JH; Kang, S; Lim, MC; Park, SY; Seo, SS; Yoo, HJ | 1 |
Chen, Q; Huang, JZ; Liang, JG; Lin, D; Shi, CM; Zhong, DT | 1 |
Bossaer, JB; Odle, BL | 1 |
Fu, K; Hao, XS; Hou, Y; Li, LF; Li, W; Liu, XM; Qian, ZZ; Qiu, LH; Wang, HQ; Zhang, HL; Zhou, SY | 1 |
Ando, M; Gemma, A; Hino, M; Kobayashi, K; Kosaihira, S; Minegishi, Y; Miyanaga, A; Mizutani, H; Nomura, K; Noro, R; Okano, T; Seike, M; Yoshimura, A | 1 |
Jaehde, U; Kloft, C; Minichmayr, I; Nock, V | 1 |
Chamberlain, MC | 1 |
Agelidou, M; Ferdoutsis, E; Georgoulias, V; Kalbakis, K; Kouroussis, Ch; Magkanas, E; Mavroudis, D; Samonis, G; Souglakos, J; Toumbis, M; Tselepatiotis, E; Tzanakis, N; Veslemes, M; Ziotopoulos, P | 1 |
Eguchi, K; Goto, K; Hojo, F; Kakinuma, R; Kodama, T; Kubota, K; Kunitoh, H; Matsumoto, T; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Tamura, T; Yoshimura, K | 1 |
Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
Boissevain, F; Bredenfeld, H; Diehl, V; Eich, H; Engert, A; Franklin, J; Josting, A; Koch, P; Koch, T; Müller-Hermelink, HK; Naumann, R; Paulus, U; Reineke, T; Rueffer, U; Sieber, M; Soekler, M; Wolf, J; Worst, P | 1 |
Au, WY; Chan, EC; Kwong, YL; Leung, AY; Liang, R; Lie, AK; Ooi, GC; Siu, LL | 1 |
Ahn, YC; Im, YH; Jung, CW; Kang, WK; Kim, H; Kim, K; Lee, KE; Lee, MH; Lee, SH; Lim, DH; Park, J; Park, K; Park, SH | 1 |
Beganovic, S; Niell, HB; Richey, S; Wan, JY | 1 |
Goto, K; Kakinuma, R; Kodama, T; Kubota, K; Kunitoh, H; Matsui, K; Matsumoto, T; Niho, S; Nishiwaki, Y; Nokihara, H; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Sugiura, T; Tamura, T; Yamamoto, N; Yoshida, K | 1 |
Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, XB; Pan, ZH; Peng, YL; Wang, W; Xia, ZJ | 1 |
Abdel-Rahman, S; Fahn, W; Fiegl, M; Issels, RD; Schlemmer, M; Wendtner, CM | 1 |
Alessandrino, EP; Banfi, L; Barbarano, L; Cairoli, R; Corso, A; De Paoli, A; Fava, S; Ferrari, D; Fiumanò, M; Frigerio, G; Isa, L; Klersy, C; Lazzarino, M; Luraschi, A; Mangiacavalli, S; Morra, E; Perego, D; Pinotti, G; Savarè, M; Ucci, G; Uziel, L; Vergani, C; Vismara, A; Zappasodi, P | 1 |
Berg, SL; Bessmertny, O; Cairo, MS; Davenport, V; Goldman, SC; Kreissman, SG; Laver, J; Reaman, GH; Secola, R; Shen, V; van de Ven, C | 1 |
Goto, A; Ishii, Y; Katagiri, T; Miyazawa, K; Ohyashiki, K | 1 |
Bergeron, C; Bernard, F; Boneu, A; Bouzy, J; Chastagner, P; Coze, C; Hartmann, O; Michon, J; Perel, Y; Plantaz, D; Rodary, C; Rubie, H; Valteau-Couanet, D | 1 |
Blayney, DW; Cruickshank, SE; Johnson, DH; McGuire, BW | 1 |
Gou, HF; Hou, M; Li, L; Qiu, M; Yan, X; Zhu, J | 1 |
Dong, M; Feng, FY; He, XH; Huang, DZ; Liu, P; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhang, P; Zhou, SY | 1 |
Ariyoshi, Y; Fukuoka, M; Furuse, K; Hatae, M; Hirabayashi, K; Noda, K; Ogawa, M; Takaku, F; Yakushiji, M | 1 |
Buchholz, E; Gatzemeier, U; Goetz, E; Groth, G; Manegold, C; Reck, M | 1 |
Hofland, KF; Jensen, PB; Sehested, M; Thougaard, AV | 1 |
Abali, H; Barista, I; Demirkazik, F; Kansu, E; Kars, A; Koc, Y; Oyan, B; Tekin, F; Tekuzman, G; Turker, A; Uner, A | 1 |
Chamorey, E; Delwail, V; Fabbro, M; Foussard, C; Gressin, R; Harrousseau, JL; Lepeu, G; Maisonneuve, H; Peyrade, F; Richard, B; Rossi, JF; Thyss, A; Vilque, JP | 1 |
Dolezal, J; Dolezel, M; Moravek, P; Odrazka, K; Petera, J; Prosvic, P; Simakova, E; Vaculikova, M; Vosmik, M; Zoul, Z | 1 |
Alberts, SR; Erlichman, C; Furth, A; Lathia, CD; Molina, JR; Reid, JM; Safgren, SL; Sloan, JA | 1 |
Astori, C; Bonfichi, M; Cafro, AM; Castagnola, C; Corso, A; Lazzarino, M; Mangiacavalli, S; Morra, E; Nosari, A; Pascutto, C; Rusconi, C; Troletti, D; Varettoni, M; Zappasodi, P | 1 |
Fan, Y; Huang, ZY; Luo, LH; Yu, HF | 1 |
Doi, S; Fukuda, M; Kasai, T; Kawabata, S; Kinoshita, A; Kohno, S; Nagashima, S; Oka, M; Soda, H; Soejima, Y; Takatani, H | 1 |
Akaza, H; Ando, S; Hinotsu, S; Kawai, K; Miyanaga, N; Oikawa, T; Sekido, N; Shimazui, T | 1 |
Aoki, S; Hirano, M; Kohori, M; Miura, I; Niitsu, N; Okamoto, M | 1 |
Bo, LJ; Chen, YH; Jin, XP; Liang, AB; Liu, B; Wang, F | 1 |
Azuma, K; Hashine, K; Karashima, T; Kasahara, K; Miura, N; Nakatsuzi, H; Numata, K; Sumiyoshi, Y | 1 |
Aydiner, A; Camlica, H; Derin, D; Guney, N; Tas, F; Topuz, E | 1 |
Harita, S; Hotta, K; Kiura, K; Kuyama, S; Okimoto, N; Segawa, Y; Shinkai, T; Tabata, M; Tanimoto, M; Ueoka, H; Yonei, T | 1 |
Akutsu, M; Inoue, K; Izumi, T; Kano, Y; Katano, S; Kobayashi, H; Masuda, Y; Muroi, K; Nagashima, T; Ohmine, K; Ozawa, K; Shirai, T; Takagi, S; Tsunoda, S; Ueda, M; Ueda, T | 1 |
Bogdanova, E; Gregory, SA; Harting, R; O'brien, T; Venugopal, P | 1 |
Aversa, SML; Bianco, A; Errante, D; Salvagno, L | 1 |
Klastersky, J; Longeval, E; Nicaise, C; Stryckmans, P | 1 |
Deboer, G; Dill, J; Evans, WK; Feld, R; Osoba, D; Shepherd, FA | 1 |
Araya, Y; Dosaka, H; Isobe, H; Ito, M; Kawakami, Y; Miyamoto, H; Onodera, S; Shimizu, T; Takaoka, K | 1 |
Chahinian, AP; Green, G; Holland, JF | 1 |
Booser, DJ; Carr, DT; Chiuten, DF; Dhingra, HM; Farha, P; Issell, BF; Murphy, WK; Spitzer, G; Umsawasdi, T; Valdivieso, M | 1 |
Aisner, J; Konits, PH; Morris, D; Van Echo, DA; Wiernik, PH | 1 |
Demitrish, M; Duffin, H; Enochs, K; Groshko, G; Lockhard, C; Maniscalco-Greb, E; Vaughn, CB | 1 |
Fehr, J; Frick, P; Gmuer, J; Honegger, H; Martz, G; Sauter, C | 1 |
Barrett, A; Fitzharris, BM; Kaye, SB; McElwain, TJ; Newlands, ES; Peckham, MJ; Saverymuttu, S | 1 |
Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U | 1 |
Fukuoka, M; Hirashima, T; Kudoh, S; Kusunoki, Y; Masuda, N; Matsui, K; Nakagawa, K; Takada, M; Tsukada, H; Yana, T | 1 |
Anderson, H; Bleehen, NM; Girling, DJ; Lallemand, G; Machin, D; Stephens, RJ; Thatcher, N | 1 |
Saeter, G; Solheim, OP; Talle, K | 1 |
Green, MR; Lilenbaum, RC; MacManus, DA | 1 |
Fehr, J; Rüegg, R; Schleiffenbaum, B; Zimmermann, D | 1 |
Crawford, J; George, M | 1 |
Ben-Shahar, M; Epelbaum, R; Haim, N | 1 |
Carey, RW; Elias, AD; Grossbard, ML; Jacobs, C; Jauss, S; Kwiatkowski, DJ; Lynch, TJ; Shulman, LN; Strauss, GM; Sugarbaker, DJ | 1 |
Beasley, K; Bunn, PA; Crowley, J; Gandara, DR; Hazuka, MB; Hicks, WJ; Kelly, K; Livingston, R; Upchurch, C; Weiss, GR | 1 |
Castello, MA; Clerico, A; Gualdi, GF; Operamolla, P; Padula, A; Properzi, E; Schiavetti, A; Trasimeni, G; Varrasso, G | 1 |
Cairo, MS | 1 |
Barcos, M; Canellos, GP; Duggan, DB; Peterson, BA; Petroni, GR | 1 |
Douglass, EC; Gajjar, AJ; Greenwald, C; Heideman, RL; Jenkins, JJ; Kellie, SJ; Kovnar, EH; Langston, JA; Li, Y; Walter, AW | 1 |
Albeck, M; Bruderman, I; Catane, R; Kalechman, Y; Kaufman, B; Shani, A; Shapira, J; Sredni, B; Tichler, T | 1 |
Watkins, SM | 1 |
Pfeiffer, P; Rose, C; Sørensen, P | 1 |
Ballestrero, A; Basta, P; Brema, F; Ferrando, F; Ghio, R; Gobbi, M; Moraglio, L; Patrone, F; Sessarego, M; Valbonesi, M | 1 |
Chessells, JM; Hirst, WJ; Layton, DM; Mieli-Vergani, G; Pritchard, J; Singh, S; Strobel, S | 1 |
Braly, PD; Howell, SB; Kim, S; Kirmani, S; McClay, EF; McClay, ME; Plaxe, SC; Wilgus, L | 1 |
Chen, RL; Hseih, KH; Huang, LM; Lee, CY; Lee, PI; Lin, DT; Lin, KH; Lin, KS; Su, IJ | 1 |
Edison, M; Gazdar, AF; Ihde, DC; Kramer, BS; Lesar, M; Linnoila, RI; Mulshine, JL; Phares, JC; Phelps, RM; Steinberg, SM | 1 |
Caglar, M; Ersoy, F; Gunay, M; Gurgey, A; Kale, G; Kucukali, T; Sayli, T | 1 |
de Wit, R; Logmans, A; Stoter, G; van den Gaast, A; van der Burg, ME; Verweij, J | 1 |
Abdel-Warith, A; Berry, J; Ezzat, AA; Khalifa, F; Khan, B; Raja, MA | 1 |
Crown, JP; Hamilton, N; Heelan, RT; Heller, G; Kritz, A; Moore, MP; Motzer, RJ; Reich, LM; Schneider, JG; Yao, TJ | 1 |
Davidson, A; Lewis, I; Pearson, AD; Pinkerton, CR; Stevens, MC | 1 |
Berdel, W; Bokemeyer, C; Clemm, C; Harstrick, A; Hohnloser, J; Illiger, HJ; Metzner, B; Räth, U; Schmoll, HJ; Siegert, W | 1 |
Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB | 1 |
Ettinger, DS; Gradishar, W; Johnson, DH; Larson, MM; Merkel, D; Schiller, JH | 1 |
Boutard, P; Brunat-Mentigny, M; Deville, A; Dusol, F; Gentet, JC; Legall, E; Mechinaud, F; Pein, F; Tournade, MF; Zucker, JM | 1 |
Achterrath, W; Berger, M; Berns, T; Fink, U; Harstrick, A; Knipp, H; Meyer, HJ; Preusser, P; Stahl, M; Wilke, H | 1 |
Boutan-Laroze, A; Chazard, M; Culine, S; Droz, JP; Kattan, J; Kramar, A; Mahjoubi, M | 1 |
Ashley, S; Holborn, J; Jones, AL; Smith, IE | 1 |
Barrada, M; Baur, M; Dittrich, C; Fazeny, B; Hudec, M; Salzer, H; Sevelda, P; Vavra, N | 1 |
Bowen, KJ; Burris, HA; Clark, GM; Eckardt, JR; Fields, SM; Kuhn, JG; Rinaldi, DA; Shaffer, DW; Smith, LS; Weiss, GR | 1 |
Ardizzoni, A; Bracarda, S; Bruzzi, P; Crinò, L; Garrone, O; Mariani, GL; Pennucci, MC; Rosso, R; Sertoli, MR; Venturini, M | 1 |
Beaujean, F; Bourhis, JH; Chazard, M; Hayat, M; Ibrahim, A; Lhomme, C; Maraninchi, D; Ostronoff, M; Viens, P; Zambon, E | 1 |
Bowman, LC; Douglass, E; Furman, W; Hudson, M; Marina, NM; Meyer, W; Rodman, J; Santana, VM; Shema, SJ; Wilimas, J | 1 |
Christiansen, NP; Davis, MP; Fay, JW; Herzig, GP; Herzig, RH; Lynch, J | 1 |
Haynes, FA; Holcenberg, J; Mayernik, DG; Neidhart, JA; Nemunaitis, J; Oette, DH; Quick, DP; Triozzi, P; Verma, S; Yau, JC | 1 |
Bromberg, C; Chmura, M; DeConti, RC; Harper, GR; Healey, B; Hilstro, J; Horton, J; Remick, SC; Ruckdeschel, JC; Sporn, J | 1 |
Creagan, ET; Eagan, RT; Foote, RL; Frytak, S; Jett, JR; Richardson, RL; Shaw, EG; Su, JQ | 1 |
Adde, M; Arndt, C; Gootenberg, J; Horak, ID; Jaffe, E; Magrath, I; Neely, J; Nieder, M; Seibel, N; Shad, A; Venzon, D; Wittes, RA | 1 |
Ariyoshi, Y; Fujita, J; Fukuoka, M; Furuse, K; Ikegami, H; Katakami, N; Negoro, S; Ota, K; Takada, M | 1 |
Bender, JG; Blake, M; Carreon, J; Lee, WJ; Oldham, F; Schilling, M; Smith, S; Swinney, P; Van Epps, D; Williams, DE; Williams, SF; Zimmerman, T | 1 |
Baars, JW; de Glas-Vos, CW; Rodenhuis, S; Thomas, BL; van der Lelie, H; van Dijk, MA; van Oers, RH; von dem Borne, AE | 1 |
Benvenuto, F; Carella, AM; Carlier, P; Chimirri, F; Dejana, A; Ferrara, RA; Florio, G; Frassoni, F; Gatti, AM; Incagliato, M; Lerma, E; Piaggio, G; Pitto, A; Podestà, M; Pollicardo, N; Prencipe, E; Soracco, M; Valbonesi, M; Vassallo, F; Vimercati, R | 1 |
Bergmann, L; Hoelzer, D; Karakas, T; Knuth, A; Lautenschläger, G; Mitrou, PS | 1 |
Asbury, RF; Boros, L; Chang, AY; Garrow, GC; Hui, L | 1 |
Bando, T; Fujimura, M; Kasahara, K; Matsuda, T; Nakatsumi, Y; Shibata, K | 1 |
Arbuck, SG; DeMaria, D; Ford, PA; Miller, LL; Minniti, C; O'Dwyer, PJ | 1 |
Anderson, N; Bern, M; Coco, F; Dow, E; Lokich, J; Moore, C | 1 |
Avila, N; Balis, FM; DeLaney, TF; Hijazi, YM; Horowitz, ME; Jacobson, J; Jarosinski, P; Steinberg, SM; Tsokos, M; Weaver-McClure, L; Wexler, LH | 1 |
Ariyoshi, Y; Fukuoka, M; Furuse, K; Kudoh, S; Kurihara, N; Kurita, Y; Ogawa, M; Sawa, T; Takada, M; Takaku, F | 1 |
Enomoto, H; Horiuchi, A; Irimajiri, K; Shirakawa, C; Tanaka, H; Yonekawa, S | 1 |
Alberts, DS; Barbhaiya, RH; Brooks, DJ; Igwemzie, LM; Kaul, S; McKinney, LM; Randolph, J; Schacter, L; Srinivas, NR; Thomas, T | 1 |
Fossella, FV; Glisson, BS; Hong, WK; Lee, JS; Murphy, WK; Perez-Soler, R; Shin, DM | 1 |
Fujii, K; Fukuda, T; Hoshino, T; Ishii, T; Komatsu, M; Masamune, O; Mikami, K; Ohshima, S; Ono, T | 1 |
Blessing, JA; Creasman, WT; Lewandowski, GS; Rose, PG; Webster, KD | 1 |
Bianco, AR; Curcio, C; D'Aprile, M; Gebbia, V; Gridelli, C; Palmeri, S; Pepe, R; Pistillucci, G; Rossi, A; Veltri, E | 1 |
Fanning, J; Hilgers, RD | 1 |
Bunn, PA; Kelly, K | 1 |
Bunn, PA | 1 |
Chen, YM; Lin, WC; Ming-Liu, J; Perng, RP; Tsai, CM; Whang-Peng, J; Yang, KY | 1 |
Niitsu, N; Umeda, M | 1 |
Buhles, W; Hersh, E; Issell, B; Neidhart, J; Rinehart, J; Triozzi, P | 1 |
Camoriano, JK; Fitch, TR; Frytak, S; Rajkumar, SV; Rubin, J | 1 |
Beck, D; Béhar, C; Bergeron, C; Bernard, JL; Bordigoni, P; Coze, C; Dusol, F; Frappaz, D; Hartmann, O; Leverger, G; Mechinaud, F; Michon, J; Otten, J; Philip, T; Plantaz, D; Plouvier, E; Rubie, H; Zucker, JM | 1 |
Gray, JR; Greco, FA; Hainsworth, JD; Hopkins, LG; Kalman, LA; Patten, JE; Stroup, SL; Thomas, M | 1 |
Allen, J; Bayer, L; Dunkel, IJ; Finlay, JL; Gardner, S; Garvin, J; Grovas, A; Halpern, S; Heller, G; Lindsley, K; Lyden, D; Mason, WP; Merchant, TE; O'Malley, B; Petriccione, MM; Puccetti, D; Rosenblum, M; Sands, S | 1 |
Fossella, F; Glisson, B; Hong, WK; Lee, JS; Murphy, WK; Palmer, J; Perez-Soler, R; Shin, DM | 1 |
Fossella, F; Glisson, B; Komaki, R; Kurie, J; Lee, JS; Murphy, WK; Perez-Soler, R; Schea, R; Shin, DM; Vadhan-Raj, S | 1 |
Minami, H; Saka, H; Sakai, S; Shimokata, K; Yamamoto, M | 1 |
Agata, H; Fujimoto, T; Hamaguchi, N; Hirota, T; Iwata, A; Katano, N; Kitagawa, S; Kobayashi, S; Konno, K; Sato, T; Sawada, K; Takeuchi, M | 1 |
Chao, Y; Chen, LT; Chen, YM; Chiou, TC; Hsieh, RK; Liu, JM; Liu, SM; Tiu, CM; Whang-Peng, J; Wu, HW | 1 |
Goya, T; Koshiishi, Y; Miya, T; Nogami, H; Sasaki, Y; Yanagida, O | 1 |
Cox, JD; Fossella, FV; Glisson, BS; Hong, WK; Komaki, R; Lee, JS | 1 |
Bernstein, SH; Christiansen, NP; Fay, JP; Herzig, GP; Pinero, L; Shah, D; Stephan, M | 1 |
Barbhaiya, RH; Fields, SZ; Himpler, BS; Igwemezie, LN; Kaul, S; Litam, PP; McAleer, C; Schacter, LP; Schilder, RJ; Wright, J | 1 |
Campion, M; Hersh, E; Levitt, D; Margolin, KA; Resta, D; Rinehart, J; Triozzi, P | 1 |
D'Incalci, M; De Fusco, M; de Jong, J; Gentili, D; Martinelli, G; Pagani, O; Sessa, C; Tinazzi, A; Torri, V; Zucchetti, M | 1 |
Angeli, A; Berruti, A; Dogliotti, L; Pia, A; Terzolo, M | 1 |
Fujii, S; Hasegawa, K; Hirabayasi, K; Ikeda, M; Izumi, R; Kono, I; Kudo, R; Niitani, H; Nishiya, I; Noda, K; Ochiai, K; Ogita, Y; Okada, H; Ozaki, M; Saito, T; Sugimori, H; Suzuoki, Y; Tanaka, K; Terashima, Y; Tomoda, Y; Umesaki, N; Yajima, A; Yakushiji, M; Yamabe, T; Yamamoto, T | 1 |
Feliu, E; Hernández, JA; Millá, F; Navarro, JT; Oriol, A; Pujol, M; Ribera, JM; Sancho, JM | 1 |
Asamoto, H; Furuse, K; Iwami, F; Kawahara, M; Kuba, M; Saijo, N; Shimoyama, M; Tamura, T | 1 |
Anton, A; Barneto, I; Font, A; Garcia-Giron, C; Moyano, AJ; Puerto, JM; Rosell, R; Salvador, A; Sanchez, JJ; Tres, A | 1 |
Bosquée, L; Canon, JL; Humblet, Y; Rosier, JF; van de Velde, H; Weynants, P | 1 |
Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
Girling, DJ; Hopwood, P; Qian, W; Sambrook, RJ; Stephens, RJ; Thatcher, N | 1 |
Bogart, JA; Chung, CT; Ryu, S; Ungureanu, C; Zamkoff, KW | 1 |
Auclerc, MF; Auvrignon, A; Baruchel, A; Bauduer, F; Berthou, C; Bordigoni, P; Demeocq, F; Lamagnere, JP; Landman-Parker, J; Leblanc, T; Legall, E; Leverger, G; Mathey, C; Michel, G; Pautard, B; Perel, Y; Schaison, G; Schneider, P | 1 |
Benz, MS; Kramer, D; Murray, TG; Scott, IU; Toledano, S | 1 |
Fueki, N; Hoshino, H; Ishihara, S; Kobayashi, G; Makimoto, T; Minato, K; Mori, M; Naruse, I; Nomoto, T; Saito, R; Sato, K; Sunaga, N; Takei, Y; Takise, A; Tsuchiya, S; Watanabe, S | 1 |
Berkowitz, R; Cannistra, SA; Kim, Y; Matulonis, U; Niloff, J; Quartulli, M; Seiden, M; Tung, N | 1 |
Fernandez, MC; Gerbing, RR; Krailo, MD; Matthay, KK | 1 |
Amoroso, D; Ballestrero, A; Boccardo, F; Ferrando, F; Garuti, A; Gonella, R; Patrone, F; Sessarego, M; Stura, P | 1 |
Barbarano, L; Bernuzzi, P; Gargantini, L; Morra, E; Nosari, A; Pungolino, E; Santoleri, L | 1 |
Fowler, JM; Greer, BE; Horowitz, IR; McGuire, WP; Rodriguez, M; Rose, PG; Waggoner, S | 1 |
Angus, B; Carey, PJ; Finney, RD; Galloway, MJ; Goff, DK; Haynes, A; Jackson, GH; Lennard, AL; Leonard, RC; McQuaker, IG; Proctor, SJ; Russell, N; Taylor, PR; Windebank, K | 1 |
Diehl, V; Engel, C; Loeffler, M; Schmitz, S; Tesch, H | 1 |
Cullen, MH; Dearnaley, DP; Fossa, SD; Harland, SJ; Horwich, A; Lallemand, E; Mead, GM; Oliver, RT; Roberts, JT; Stenning, SP; Wilkinson, PM | 1 |
Burris, HA; Erland, JB; Gray, JR; Greco, FA; Hainsworth, JD; Kalman, LA; Schreeder, MT | 1 |
Brown, JM; Gurney, EM; Hepburn, PM; Johnson, PW; Muers, MF; Napp, VV; Peake, MD; Poulter, KM | 1 |
Dempke, W; Kellner, O; Schmoll, HJ; von Poblozki, A; Wolf, HH | 1 |
Bourg, V; Chichmanian, RM; Frenay, M; Lebrun, C; Thomas, P | 1 |
Agelidou, M; Bania, E; Georgoulias, V; Jordanoglou, J; Kakolyris, S; Kouroussis, C; Mavroudis, D; Papadakis, E; Stavrakakis, J; Tsiafaki, X; Veslemes, M; Vlachonicolis, J | 1 |
Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A | 1 |
Berthold, F; Fichtner, I; Fulda, S; Hero, B | 1 |
Bunn, PA; Crowley, JJ; Gandara, DR; Kelly, K; Livingston, RB; Lovato, L; Roychowdhury, D; Taylor, SA; Zangmeister, J | 1 |
Fukuoka, M; Hirashima, T; Kobayashi, M; Masuda, N; Matsui, K; Nitta, T; Takada, Y; Yana, T | 1 |
Barcos, M; Bloomfield, CD; Freter, CE; Frizzera, G; Johnson, JL; Lee, EJ; Peterson, BA; Petroni, GR; Schiffer, CA | 1 |
Briassoulis, E; Fountzilas, G; Kalofonos, HP; Kardamakis, D; Kosmidis, P; Kouvatseas, G; Panoussaki, E; Pavlidis, N; Samantas, E; Skarlos, DV; Tsavdaridis, D; Tsekeris, P; Tsiakopoulos, E; Tzitzikas, J; Zamboglou, N | 1 |
Bernstein, M; Devidas, M; Ferguson, W; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Link, M; Schwartz, CL; Siegal, GP | 1 |
Gatzemeier, U; Hossfeld, DK; Laumen, R; Lenaz, L; Neuhauss, R; Reck, M; von Pawel, J | 1 |
DeVore, R; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Thomas, M; Walls, J | 1 |
Piers, DA; Postmus, PE; Smit, EF | 1 |
Arpin, D; Bohas, C; Caillet, B; Fournel, P; Lasset, C; Pacheco, Y; Perol, M; Rebattu, P; Riou, R; Trillet-Lenoir, V | 1 |
Hansen, HH; Hansen, M; Hansen, OP; Lund, B | 1 |
Green, MR; Mason, JR; Mullen, M; Newton, B; Shea, TC; Storniolo, AM; Taetle, R | 1 |
Bowman, LC; Brenner, MK; Mirro, J; Santana, VM; Schell, MJ; Thompson, EI; Williams, R | 1 |
Becton, DL; Berry, DH; Kletzel, M | 1 |
Flaherty, L; Heilbrun, L; Kraut, M; Martino, S; Redman, B; Valdivieso, M; Wozniak, A | 1 |
Hardy, JR; Pinkerton, CR | 1 |
de Vries, EG; Gietema, JA; Mulder, NH; Oldhoff, J; Sleijfer, DT; Willemse, PH | 1 |
de Vries, EG; Smit, AJ; van Essen, LH | 1 |
Anderson, N; Bern, M; Lokich, J; Moore, C | 1 |
Achterrath, W; Eiermann, W; Hepp, H; Lenaz, L | 1 |
Bowman, LC; Douglass, EC; Evans, WE; Fairclough, DL; Furman, WL; Huhn, RD; Petros, WP; Pratt, CB; Santana, VM; Stute, N | 1 |
Frazier, SR; Greco, FA; Hainsworth, JD; Johnson, DH | 1 |
Ashley, SA; Ford, HT; Forgeson, GV; Perren, TJ; Smith, IE; Woodiwiss, J; Yarnold, JR | 1 |
Blancy, E; Bugat, R; Canal, P; Chatelut, E; Chevreau, C; Houin, G; Lequellec, A; Roche, H | 1 |
Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Strupp, J | 1 |
Arriagada, R; Daurès, JP; Douillard, JY; Dubois, JB; Godard, P; Le Chevalier, T; Mary, H; Pujol, JL; Rossi, JF; Rouanet, P | 1 |
Anderson, T; Kohler, W; Mangalik, A; Neidhart, JA; Plauche, A; Quenzer, RW; Rinehart, JJ; Stidley, C | 1 |
Pizzillo, MF; Salva, KM; Schwartz, EL; Sparano, JA; Wadler, S; Wiernik, PH | 1 |
Browne, MJ; Calabresi, P; Clark, JW; Cummings, FJ; Curt, G; Posner, M; Slapak, CA; Urba, S; Weitberg, A; Wiemann, M | 1 |
Gradishar, WJ; Kies, MS; Vokes, EE | 1 |
Collins, C; Griffin, BR; Higano, CS; Keppen, MD; Livingston, RB; Miller, TP | 1 |
Hiraki, S; Kawahara, S; Kiura, K; Moritaka, T; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Yamashita, H; Yonei, T | 1 |
Bungo, M; Fujita, J; Futami, H; Hashimoto, Y; Hata, Y; Irino, S; Iuchi, Y; Kamei, M; Nakamura, H; Yamaji, Y | 1 |
Andoh, T; Hayashi, H; Kiyama, T; Miyamoto, M; Mizutani, T; Nishi, K; Nomura, T; Onda, M; Tokunaga, A; Umehara, M | 1 |
de Vries, EG; Koops, HS; Maas, A; Mulder, NH; Mulder, PO; Sleijfer, DT; Splinter, T; van der Geest, S | 1 |
Bazos, MJ; DeBoer, G; Evans, WK; Feld, R; Osoba, D; Shepherd, FA | 1 |
Greco, FA; Grosh, WW; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN | 1 |
Abeloff, MD; Berkman, AW; Markman, M; Waterfield, WC | 1 |
Alberto, P; Cavalli, F; Joss, R; Kaplan, S; Martz, G; Mermillod, B; Obrecht, JP | 1 |
DeLeo, MJ; Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Wolff, SN | 1 |
Klastersky, J; Sculier, JP; Tueni, E | 1 |
Ehninger, G; Freund, M; Heil, G; Hoelzer, D; Kurrle, E; Link, H; Mitrou, PS; Ohl, S; Queisser, W; Schlimok, G | 1 |
Bakker, PJ; Danner, SA; Lange, JM; Veenhof, KH | 1 |
Bowman, A; Chessells, JM; Holtzel, H; Pinkerton, CR | 1 |
Armitage, JO; Cabanillas, FF; Dicke, KA; Horwitz, LJ; Jagannath, S; Spitzer, G; Vellekoop, L; Zander, AR | 1 |
Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S | 1 |
Hashimoto, S; Kano, A; Kawamoto, K; Konno, K; Sakata, Y; Sato, S; Takahashi, H; Wakui, A; Yokoyama, M; Yoshida, Y | 1 |
Ito, K; Kobayashi, K; Matsuda, T; Nakagoshi, T; Nakamura, E; Nakamura, S; Nakanishi, J; Natori, K; Ohtake, S; Yoshida, T | 1 |
Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Kohsaki, M; Konishi, I; Masaoka, T; Nagai, K; Shibata, H; Tsubaki, K | 1 |
7 review(s) available for etoposide and Thrombopenia
Article | Year |
---|---|
Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis.
Topics: Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Diarrhea; Etoposide; Fatigue; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Nausea; Neoplasm Staging; Neutropenia; Odds Ratio; Proportional Hazards Models; Small Cell Lung Carcinoma; Thrombocytopenia; Vomiting | 2017 |
The impact of dose per cycle of etoposide and cisplatin on outcomes in patients with extensive small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Humans; Leukopenia; Lung Neoplasms; Neoplasm Staging; Neutropenia; Randomized Controlled Trials as Topic; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2004 |
The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Interleukin-6; Lung Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1995 |
The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Neoplasms; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Wilms Tumor | 1995 |
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Hypertension; Immunoglobulins, Intravenous; Male; Middle Aged; Plasma; Remission Induction; Renal Insufficiency; Retinal Vein Occlusion; Thiotepa; Thrombocytopenia; Transplantation, Autologous; Vincristine | 1995 |
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia; Treatment Outcome | 1996 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
134 trial(s) available for etoposide and Thrombopenia
Article | Year |
---|---|
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Carboplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Neutropenia; Small Cell Lung Carcinoma; Thrombocytopenia | 2023 |
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial).
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; DNA, Viral; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Prednisone; Progression-Free Survival; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Viral Load; Vorinostat | 2020 |
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Histone Deacetylase Inhibitors; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Panobinostat; Survival Rate; Thrombocytopenia; Treatment Outcome; Young Adult | 2018 |
Dose-adjusted EPOCH chemotherapy for untreated peripheral T-cell lymphomas: a multicenter phase II trial of West-JHOG PTCL0707.
Topics: Adult; Age Factors; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Neutropenia; Prednisone; Thrombocytopenia; Treatment Outcome; Vincristine | 2017 |
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2013 |
Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placeb
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cough; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Vincristine | 2015 |
A phase 1 safety study of veliparib combined with cisplatin and etoposide in extensive stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E2511).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Etoposide; Fatigue; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Small Cell Lung Carcinoma; Thrombocytopenia | 2015 |
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hematologic Tests; Hodgkin Disease; Humans; Prednisone; Procarbazine; Thrombocytopenia; Vincristine | 2016 |
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Boronic Acids; Bortezomib; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neoplasms; Neutropenia; Pyrazines; Thrombocytopenia | 2009 |
[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult | 2008 |
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Young Adult | 2009 |
[Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Levoleucovorin; Male; Middle Aged; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Stomach Neoplasms; Survival Rate; Thrombocytopenia; Vomiting | 2009 |
[Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Leukopenia; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Neoplasm Staging; Remission Induction; Stem Cell Transplantation; Thrombocytopenia; Vincristine; Vindesine | 2009 |
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Male; Metabolic Clearance Rate; Neuroblastoma; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome | 2010 |
Multicentre phase II study of CyclOBEAP plus rituximab in patients with diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisolone; Prognosis; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult | 2010 |
[A prospective randomized study of the radiotherapy volume for limited-stage small cell lung cancer: a preliminary report].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Lung Injury; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiotherapy; Radiotherapy Dosage; Small Cell Lung Carcinoma; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Tumor Burden | 2010 |
Duration: escalation study of oral etoposide with carboplatin in patients with varied solid tumors.
Topics: Administration, Oral; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Neoplasms; Neutropenia; Salvage Therapy; Thrombocytopenia | 2010 |
Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease Progression; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platelet Transfusion; Small Cell Lung Carcinoma; Survival Analysis; Thrombocytopenia | 2011 |
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nausea; Neutropenia; Nose Neoplasms; Prednisone; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine; Vomiting | 2011 |
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Tamoxifen; Thrombocytopenia; Treatment Outcome | 2011 |
Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Thrombocytopenia; Treatment Outcome | 2012 |
Combination chemotherapy of alternating etoposide and carboplatin with weekly administration of irinotecan and cisplatin in extensive-stage small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Diarrhea; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Severity of Illness Index; Small Cell Lung Carcinoma; Thrombocytopenia; Treatment Outcome | 2012 |
Salvage chemotherapy for recurrent spinal cord ependymona.
Topics: Administration, Oral; Adult; Alopecia; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Spinal Cord Neoplasms; Thrombocytopenia; Treatment Outcome; Weight Loss | 2002 |
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease Progression; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival; Thrombocytopenia; Topotecan; Treatment Outcome | 2002 |
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Diarrhea; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival; Thrombocytopenia | 2003 |
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukopenia; Male; Middle Aged; Prednisone; Procarbazine; Survival; Thrombocytopenia; Treatment Outcome; Vincristine | 2003 |
A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Radiation Pneumonitis; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2003 |
Multi-institutional phase II trial of irinotecan, cisplatin, and etoposide for sensitive relapsed small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Salvage Therapy; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2004 |
Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Hyperthermia, Induced; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasm Staging; Patient Selection; Salvage Therapy; Sarcoma; Survival Rate; Thrombocytopenia; Treatment Outcome | 2004 |
The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoadjuvant Therapy; Neutropenia; Thrombocytopenia; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Interleukin-11; Lymphoma; Male; Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia | 2005 |
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
[Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nausea; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 2005 |
[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Edema; Etoposide; Female; Fever; Humans; Interleukin-11; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia | 2005 |
Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Topotecan; Treatment Outcome | 2005 |
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Pyruvaldehyde; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biphenyl Compounds; Carboplatin; Cohort Studies; Colonic Neoplasms; Enzyme Inhibitors; Etoposide; Female; Humans; Male; Matrix Metalloproteinase Inhibitors; Melanoma; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Neutropenia; Organic Chemicals; Phenylbutyrates; Thrombocytopenia; Thymoma; Treatment Outcome; Vomiting | 2005 |
Efficacy, toxicity and feasibility of a shorter schedule of DCEP regimen for stem cell mobilization in multiple myeloma.
Topics: Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Etoposide; Feasibility Studies; Hematopoietic Stem Cell Mobilization; Humans; Infections; Multiple Myeloma; Neutropenia; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Thrombocytopenia | 2005 |
A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Small Cell; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Etoposide; Female; Gastrointestinal Tract; Humans; Injections, Intravenous; Liver Function Tests; Lung Neoplasms; Male; Nausea; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting | 2006 |
Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisolone; Remission Induction; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine | 2006 |
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Diarrhea; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2007 |
Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Cytarabine; Etoposide; Female; Humans; Lymphoma, B-Cell; Male; Methylprednisolone; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Platelet Count; Prospective Studies; Rituximab; Thrombocytopenia; Treatment Outcome | 2007 |
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Thrombocytopenia; Vomiting | 1984 |
Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Infusions, Parenteral; Leukopenia; Middle Aged; Podophyllotoxin; Thrombocytopenia | 1982 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diarrhea; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Half-Life; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Remission Induction; Thrombocytopenia | 1994 |
A phase I trial of paclitaxel and etoposide for metastatic or recurrent malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia | 1995 |
Prolonged daily administration of oral etoposide in lymphoma following prior therapy with adriamycin, an ifosfamide-containing salvage combination, and intravenous etoposide.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Palliative Care; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia | 1995 |
A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Drug Tolerance; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Thrombocytopenia | 1995 |
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Thrombocytopenia | 1995 |
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukopenia; Logistic Models; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Proportional Hazards Models; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; United States; Vinblastine; Vincristine | 1995 |
Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vincristine | 1995 |
Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Non-Small-Cell Lung; Colony-Stimulating Factors; Ethylenes; Etoposide; Female; Humans; Interleukin-1; Interleukin-6; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Thrombocytopenia | 1995 |
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Remission Induction; Thrombocytopenia; Vincristine | 1995 |
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Carcinoma; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Parenteral; Ovarian Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1995 |
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Prospective Studies; Remission Induction; Survival Rate; Thrombocytopenia; Weight Loss | 1994 |
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction; Thrombocytopenia | 1994 |
Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neutropenia; Thrombocytopenia | 1993 |
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasm Metastasis; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome | 1993 |
Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Treatment Outcome | 1994 |
Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Infant; Kidney Neoplasms; Male; Neoplasm Staging; Remission Induction; Thrombocytopenia; Wilms Tumor | 1994 |
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia; Treatment Outcome | 1994 |
High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neutropenia; Prospective Studies; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome | 1993 |
CVM versus ACE in the treatment of small cell lung cancer.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant, Newborn; Infections; Leukopenia; Lung Neoplasms; Male; Methotrexate; Middle Aged; Thrombocytopenia; Treatment Outcome; Vinblastine | 1993 |
Etoposide and carboplatin as salvage and first-line therapy in ovarian cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Remission Induction; Salvage Therapy; Thrombocytopenia | 1993 |
A randomized phase I trial of chronic oral etoposide with or without granulocyte-macrophage colony-stimulating factor in patients with advanced malignancies.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Thrombocytopenia | 1993 |
Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infant; Least-Squares Analysis; Male; Neoplasms; Neutropenia; Thrombocytopenia; Treatment Outcome | 1993 |
Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating-factor support for dose-intensive cyclophosphamide, etoposide, and cisplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Transfusion; Breast Neoplasms; Cisplatin; Cyclophosphamide; Double-Blind Method; Etoposide; Female; Gastrointestinal Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Length of Stay; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Platelet Count; Thrombocytopenia; Treatment Outcome | 1996 |
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Confidence Intervals; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting | 1996 |
Infusion cisplatin chemotherapy and hyperfractionated thoracic radiotherapy for small-cell lung cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Small Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Lung; Lung Neoplasms; Neoplasm Staging; Radiation Pneumonitis; Remission Induction; Survival Rate; Thrombocytopenia | 1996 |
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 1996 |
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Thrombocytopenia | 1996 |
Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer.
Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Culture Techniques; Cells, Cultured; Combined Modality Therapy; Culture Media; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Leukapheresis; Lewis X Antigen; Melphalan; Middle Aged; Neutropenia; Tamoxifen; Thiotepa; Thrombocytopenia | 1996 |
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Cisplatin; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunologic Factors; Interferon-alpha; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Neoplasm, Residual; Neoplastic Cells, Circulating; Philadelphia Chromosome; Survival Analysis; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma--a randomised pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pilot Projects; Prednisone; Prospective Studies; Recombinant Proteins; Remission Induction; Survival Analysis; Thrombocytopenia; Vincristine | 1995 |
Analysis of thrombocytopenia due to carboplatin combined with etoposide in elderly patients with lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Evaluation Studies as Topic; Female; Humans; Lung Neoplasms; Male; Retrospective Studies; Thrombocytopenia | 1996 |
Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1996 |
Pilot study of ambulatory infusional delivery of a multidrug regimen: ifosfamide, carboplatin and etoposide (ICE).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1996 |
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Heart Failure; Humans; Ifosfamide; Male; Neutropenia; Pilot Projects; Sarcoma, Ewing; Soft Tissue Neoplasms; Thrombocytopenia; Vincristine | 1996 |
Phase II study of recombinant human interleukin 3 administration following carboplatin and etoposide chemotherapy in small-cell lung cancer patients. SDZ ILE 964 (IL-3) Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Interleukin-3; Lung Neoplasms; Male; Middle Aged; Recombinant Proteins; Thrombocytopenia | 1996 |
Phase I and pharmacokinetic study of etoposide phosphate.
Topics: Adult; Aged; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; Etoposide; Humans; Middle Aged; Neoplasms; Organophosphorus Compounds; Regression Analysis; Thrombocytopenia | 1995 |
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Administration, Oral; Cohort Studies; Endometrial Neoplasms; Etoposide; Female; Humans; Leukopenia; Neoplasm Recurrence, Local; Thrombocytopenia; Time Factors | 1996 |
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Carcinoma, Small Cell; Cause of Death; Dose-Response Relationship, Drug; Drug Tolerance; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Sepsis; Thrombocytopenia | 1996 |
Prophylactic granulocyte colony-stimulating factor allows escalation of chemotherapeutic dose intensity in advanced epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Middle Aged; Neutropenia; Ovarian Neoplasms; Thrombocytopenia | 1996 |
Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Survival Rate; Thrombocytopenia | 1996 |
The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Etoposide; Humans; Lung Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia; Treatment Outcome | 1996 |
Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1997 |
Evaluation of long-term daily administration of oral low-dose etoposide in elderly patients with relapsing or refractory non-Hodgkin's lymphoma.
Topics: Administration, Oral; Age Factors; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Resistance, Neoplasm; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Recurrence; Remission Induction; Survival Analysis; Thrombocytopenia; Time Factors | 1997 |
Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Interleukin-1; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1997 |
Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cause of Death; Cisplatin; Clinical Trials, Phase II as Topic; Cochlea; Digestive System Neoplasms; Drug Administration Schedule; Drug Synergism; Esophageal Neoplasms; Etoposide; Evaluation Studies as Topic; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Remission Induction; Sepsis; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1997 |
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Infant; Infections; Infusions, Intravenous; Leukopenia; Male; Neuroblastoma; Neutropenia; Thrombocytopenia; Treatment Outcome; Vincristine | 1997 |
Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis; Thrombocytopenia | 1997 |
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Etoposide; Female; Granulocytes; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting | 1998 |
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1998 |
A phase II study of carboplatin and prolonged administration of oral etoposide in patients with small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Rate; Thrombocytopenia | 1997 |
The influence of relative body weight on toxicity of combination chemotherapy with cisplatin and etoposide.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Body Surface Area; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Creatinine; Esophageal Neoplasms; Etoposide; Female; Hematologic Tests; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Sex Factors; Thrombocytopenia | 1998 |
Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Interleukin-3; Leukocyte Count; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Platelet Count; Premedication; Safety; Thrombocytopenia; Treatment Outcome | 1997 |
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5.
Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Half-Life; Hemoglobins; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds; Thrombocytopenia | 1995 |
Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Interleukin-3; Male; Middle Aged; Neoplasms; Neutrophils; Platelet Count; Platelet Transfusion; Recombinant Proteins; Thrombocytopenia | 1995 |
Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Topics: Administration, Oral; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Mitotane; Prospective Studies; Thrombocytopenia; Treatment Outcome | 1998 |
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Uterine Cervical Neoplasms | 1998 |
Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
Topics: Administration, Oral; Adult; Aged; Alopecia; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vomiting | 1998 |
Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group.
Topics: Adult; Aged; Agranulocytosis; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1999 |
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clini
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Nervous System Neoplasms; Neutropenia; Recurrence; Survival Rate; Thoracic Neoplasms; Thrombocytopenia; Treatment Outcome | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomize
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Quality of Life; Thrombocytopenia | 2000 |
Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infant; Infant, Newborn; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vincristine | 2000 |
A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Esophagitis; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2000 |
Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome | 2000 |
A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Neuroblastoma; Neutropenia; Thrombocytopenia; Treatment Outcome | 2000 |
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin.
Topics: Adenocarcinoma; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Cytokines; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukocyte Count; Middle Aged; Neutropenia; Thrombocytopenia | 2000 |
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Thrombocytopenia | 2000 |
High dose ifosfamide in combination with etoposide and epirubicin followed by autologous stem cell transplantation in the treatment of relapsed/refractory Hodgkin's disease: a report on toxicity and efficacy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Prognosis; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome | 2000 |
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Blood Transfusion; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Count; Prednisone; Procarbazine; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine | 2000 |
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Seminoma; Survival Analysis; Testicular Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome | 2000 |
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia | 2001 |
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Fatigue; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Paclitaxel; Survival Rate; Thrombocytopenia; Treatment Outcome; Vomiting | 2001 |
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.
Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays | 2001 |
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Fatigue; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Paclitaxel; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting | 2001 |
Carboplatin calculated with Chatelut's formula plus etoposide for elderly patients with small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Neutropenia; Severity of Illness Index; Thrombocytopenia; Treatment Outcome | 2001 |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infections; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Survival Analysis; Thrombocytopenia; Vincristine | 2001 |
Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome | 2001 |
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Thrombocytopenia; Treatment Outcome | 2002 |
Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Drug Evaluation; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Recurrence; Thrombocytopenia; Time Factors; Vincristine | 1992 |
Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neutropenia; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia | 1992 |
Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Epirubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1992 |
[Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Survival Analysis; Thrombocytopenia | 1992 |
A dose-escalation study of carboplatin/cyclophosphamide/etoposide along with autologous bone marrow or peripheral blood stem cell rescue.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Bone Marrow Transplantation; Candidiasis; Carboplatin; Clinical Trials, Phase I as Topic; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intravenous; Male; Neutropenia; Remission Induction; Stem Cells; Survival Rate; Thrombocytopenia | 1992 |
Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Thrombocytopenia | 1992 |
5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia | 1991 |
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Humans; Infections; Leukemia, Myeloid, Acute; Middle Aged; Neutropenia; Remission Induction; Thrombocytopenia | 1988 |
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting | 1985 |
107 other study(ies) available for etoposide and Thrombopenia
Article | Year |
---|---|
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Middle Aged; Neutropenia; Progression-Free Survival; Radiotherapy; Rare Diseases; Risk; Thrombocytopenia; Young Adult | 2020 |
Splenic embolization to continue chemotherapy in a child with hypersplenism-related thrombocytopenia.
Topics: Antineoplastic Agents; Child; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Embolization, Therapeutic; Etoposide; Female; Humans; Hypersplenism; Ifosfamide; Thrombocytopenia; Vincristine | 2021 |
Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hepatic Encephalopathy; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Sepsis; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; Uganda; Vincristine | 2020 |
Individual prediction of thrombocytopenia at next chemotherapy cycle: Evaluation of dynamic model performances.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Lymphoma, Non-Hodgkin; Thrombocytopenia | 2021 |
[A Case of Merkel Cell Carcinoma Complicated with Severe Thrombocytopenia Treated with Carboplatin/Etoposide Regimen after Surgery].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Merkel Cell; Etoposide; Female; HLA Antigens; Humans; Platelet Transfusion; Skin Neoplasms; Thrombocytopenia | 2017 |
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Topics: Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Female; Health Status; Humans; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia | 2018 |
Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carboplatin; Cisplatin; Etoposide; Female; Glucuronosyltransferase; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Neutropenia; Polymorphism, Genetic; Retrospective Studies; Small Cell Lung Carcinoma; Thrombocytopenia | 2019 |
A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Deoxycytidine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisolone; Progression-Free Survival; Retrospective Studies; Thrombocytopenia; Vincristine; Young Adult | 2019 |
Lamotrigine-associated hemophagocytic lymphohistiocytosis.
Topics: Biopsy; Bone Marrow; Dexamethasone; Drug Resistant Epilepsy; Etoposide; Ferritins; Humans; Interleukin-2 Receptor alpha Subunit; Lacosamide; Lamotrigine; Leukopenia; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Thrombocytopenia; Transaminases | 2019 |
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia | 2017 |
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2015 |
[Efficiency and adverse effects of the effective therapy applying etoposide + cisplatin and its subsequent maintenance therapy with different durations in patients with small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Humans; Hypokinesia; Leukopenia; Lung Neoplasms; Nausea; Neutropenia; Remission Induction; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Thrombocytopenia; Vomiting | 2016 |
Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
Topics: Adolescent; Adult; Antigens, CD34; Child; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Male; Middle Aged; Neutropenia; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome; Vomiting | 2009 |
Factors for hematopoietic toxicity of carboplatin: refining the targeting of carboplatin systemic exposure.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cell Proliferation; Deoxycytidine; Etoposide; Female; France; Gemcitabine; Humans; Leukocyte Count; Male; Middle Aged; Models, Biological; Neutropenia; Neutrophils; Paclitaxel; Platelet Count; Prospective Studies; Risk Assessment; Risk Factors; Thrombocytopenia; Young Adult | 2010 |
Risk factors for early death in children with haemophagocytic lymphohistiocytosis.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Ferritins; Fever; Humans; Hyperbilirubinemia; Immunosuppressive Agents; Leukocytosis; Lymphohistiocytosis, Hemophagocytic; Male; Prognosis; Proportional Hazards Models; Risk Factors; Thrombocytopenia | 2012 |
Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leukopenia; Male; Retrospective Studies; Sarcoma, Kaposi; Thrombocytopenia; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine | 2012 |
Probable etoposide interaction with Echinacea.
Topics: Antineoplastic Agents, Phytogenic; Blood Platelets; Carcinoma, Non-Small-Cell Lung; Cytochrome P-450 CYP3A Inhibitors; Dietary Supplements; Echinacea; Etoposide; Herb-Drug Interactions; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Platelet Count; Thrombocytopenia | 2012 |
[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Remission Induction; Retrospective Studies; Rituximab; Survival Rate; Thrombocytopenia; Vinblastine; Vinorelbine; Young Adult | 2012 |
Thrombocytopenia following high-dose chemotherapy with carboplatin, etoposide and thiotepa in patients with testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Male; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Thiotepa; Thrombocytopenia | 2013 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Neutropenia; Recurrence; Remission Induction; Thrombocytopenia; Tomography, X-Ray Computed; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
[Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prednisone; Remission Induction; Survival Rate; Thrombocytopenia; Treatment Outcome; Vincristine | 2004 |
[Successful treatment of acute myelomonocytic leukemia developed from essential thrombocythemia with cytarabine plus etoposide].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Humans; Leukemia, Myelomonocytic, Acute; Male; Thrombocytopenia; Treatment Outcome | 2004 |
[Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thrombocytopenia; Transplantation, Autologous | 2005 |
Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
Topics: Anemia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cardiovascular Agents; Cell Culture Techniques; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Etoposide; Female; Leukopenia; Mice; Neutropenia; Razoxane; Thrombocytopenia | 2005 |
IIVP salvage regimen induces high response rates in patients with relapsed lymphoma before autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Etoposide; Female; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Infections; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Salvage Therapy; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome | 2005 |
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
Topics: Aged; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Dexamethasone; Disease Progression; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Hormones; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome | 2005 |
[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Leukopenia; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Mitoguazone; Recurrence; Remission Induction; Retrospective Studies; Survival Rate; Thrombocytopenia; Vinblastine | 2005 |
Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Drug Administration Schedule; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Prognosis; Recombinant Proteins; Serotonin Antagonists; Survival Rate; Testicular Neoplasms; Thrombocytopenia | 2006 |
[Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Salvage Therapy; Thrombocytopenia; Young Adult | 2006 |
Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Estramustine; Etoposide; Humans; Leukopenia; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Thrombocytopenia | 2007 |
Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Time Factors; Topotecan | 2007 |
[MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, and etoposide) as a low-dose salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Hydrocortisone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Piperazines; Salvage Therapy; Survival Rate; Thrombocytopenia; Vincristine | 2007 |
Comment on: 'Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome'.
Topics: Administration, Oral; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Multicenter Studies as Topic; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine | 2008 |
Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.
Topics: Adult; Aged; Agranulocytosis; Bone Marrow Transplantation; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukocyte Count; Male; Middle Aged; Pilot Projects; Podophyllotoxin; Thrombocytopenia | 1982 |
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia; Time Factors | 1984 |
[Effects of oral etoposide in small cell carcinoma of the lung].
Topics: Administration, Oral; Adult; Aged; Capsules; Carcinoma, Small Cell; Etoposide; Humans; Leukopenia; Lung Neoplasms; Male; Nausea; Podophyllotoxin; Thrombocytopenia | 1984 |
Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Thrombocytopenia | 1984 |
VP-16 and adriamycin in patients with advanced breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Podophyllotoxin; Prednisone; Thrombocytopenia; Vincristine; Vomiting | 1982 |
Acute myelogenous leukemia: successful treatment of relapse with cytosine arabinoside, VP 16-213, vincristine and vinblastine (A-triple-V).
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Thrombocytopenia; Vinblastine; Vincristine | 1982 |
VP16-213 as a single agent in advanced testicular tumors.
Topics: Drug Evaluation; Dysgerminoma; Etoposide; Humans; Leukopenia; Male; Podophyllotoxin; Teratoma; Testicular Neoplasms; Thrombocytopenia | 1980 |
The feasibility of using glycosylated recombinant human granulocyte colony-stimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer. Medical Research
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Palliative Care; Thrombocytopenia | 1995 |
Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Leukopenia; Neoplasm Staging; Neutropenia; Sarcoma; Thrombocytopenia; Time Factors | 1995 |
High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunophenotyping; Killer Cells, Natural; Leukocyte Count; Lymphoma; Male; Prednisone; Spleen; Splenectomy; Thrombocytopenia; Vincristine | 1995 |
Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Male; Thrombocytopenia | 1995 |
Predicting neutropenia after chemotherapy for lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukocyte Count; Lymphoma; Male; Mechlorethamine; Middle Aged; Neutropenia; Predictive Value of Tests; Prednisolone; Procarbazine; Retrospective Studies; Risk Factors; Thrombocytopenia; Vinblastine; Vincristine | 1993 |
Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Radiotherapy, Adjuvant; Thrombocytopenia | 1995 |
Haemophagocytic lymphohistiocytosis: experience at two U.K. centres.
Topics: Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Etoposide; Female; Fibrinogen; Follow-Up Studies; Histiocytosis, Non-Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Methotrexate; Methylprednisolone; Retrospective Studies; Survival Analysis; Thrombocytopenia; Treatment Outcome; United Kingdom | 1994 |
Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis.
Topics: Adolescent; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Fever; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 6, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Infant; Male; Prognosis; Thrombocytopenia; Treatment Outcome | 1995 |
High-dose methylprednisolone and VP-16 in treatment of Griscelli syndrome with central nervous system involvement.
Topics: Albinism; Central Nervous System Diseases; Child; Etoposide; Female; Fever; Humans; Leukopenia; Methylprednisolone; Movement Disorders; Syndrome; Thrombocytopenia | 1994 |
E-SHAP: an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Neutropenia; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia | 1994 |
21-day schedule oral etoposide in children--a feasibility study.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Leukemia; Leukopenia; Male; Neuroblastoma; Neutropenia; Sarcoma; Thrombocytopenia; Treatment Outcome | 1993 |
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia | 1994 |
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Feasibility Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Time Factors | 1993 |
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Prognosis; Prospective Studies; Salvage Therapy; Thrombocytopenia | 1993 |
Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant Group.
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-3; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Thrombocytopenia; Treatment Outcome | 1996 |
Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Paclitaxel; Pilot Projects; Remission Induction; Sarcoma; Thrombocytopenia | 1996 |
[Immunoblastic lymphadenopathy-like T cell lymphoma associated with erythroid hypoplasia and thrombocytopenia].
Topics: Aged; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Thrombocytopenia | 1996 |
Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Topotecan | 1996 |
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Injections, Intravenous; Lentinan; Leukopenia; Liver Neoplasms; Male; Nausea; Stomach Neoplasms; Tegafur; Thrombocytopenia; Uracil | 1996 |
Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Transplantation, Autologous; Vincristine | 1998 |
[Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Child; Drug Administration Schedule; Etoposide; Female; Fever; Humans; Ifosfamide; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neutropenia; Osteosarcoma; Pilot Projects; Thrombocytopenia | 1998 |
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cisplatin; Drug Administration Schedule; Etoposide; Female; Hepatitis B; Hepatitis C; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms, Unknown Primary; Taiwan; Thrombocytopenia; Virus Diseases | 1998 |
A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Pilot Projects; Radiotherapy Dosage; Survival Analysis; Thrombocytopenia; Treatment Failure | 1998 |
Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents, Phytogenic; Biological Availability; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Thrombocytopenia | 1995 |
Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
Topics: Acute Disease; Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Hemorrhage; Humans; Idarubicin; Leukemia, Myeloid; Middle Aged; Mitoxantrone; Pancytopenia; Platelet Count; Platelet Transfusion; Retrospective Studies; Spain; Thrombocytopenia | 1998 |
Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease Progression; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Count; Radiation Injuries; Radiotherapy, Adjuvant; Retrospective Studies; Thrombocytopenia; Transplantation, Autologous | 2000 |
Complications of systemic chemotherapy as treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclosporine; Cytarabine; Etoposide; Female; Fever; Humans; Infant; Male; Methotrexate; Neutropenia; Organophosphorus Compounds; Retinal Neoplasms; Retinoblastoma; Thrombocytopenia; Vincristine | 2000 |
Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Prednimustine; Thrombocytopenia; Treatment Outcome | 2000 |
Carcinoma of unknown primary site.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials, Phase II as Topic; Etoposide; Fatigue; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms, Unknown Primary; Paclitaxel; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vomiting | 2000 |
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Topics: Algorithms; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Diagnosis, Differential; Disseminated Intravascular Coagulation; Etoposide; Female; Fluorouracil; Hemorrhagic Disorders; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Precancerous Conditions; Stomach; Stomach Neoplasms; Thrombocytopenia | 2000 |
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity.
Topics: Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Drug Interactions; Epilepsy; Etoposide; Female; Glioma; Hematologic Tests; Humans; Male; Middle Aged; Neutropenia; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Thrombocytopenia; Valproic Acid | 2001 |
Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Leukopenia; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate; Thrombocytopenia | 1992 |
Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dermatitis, Exfoliative; Diarrhea; Etoposide; Female; Humans; Infant; Male; Neuroblastoma; Stomatitis; Thrombocytopenia; Vincristine | 1992 |
Carboplatin dose optimization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Drug Administration Schedule; Etoposide; Humans; Neutropenia; Organoplatinum Compounds; Thrombocytopenia | 1990 |
Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Humans; L-Lactate Dehydrogenase; Leukopenia; Male; Middle Aged; Thrombocytopenia; Vinblastine | 1991 |
Successful long-term control of idiopathic hypereosinophilic syndrome with etoposide.
Topics: Adult; Cardiomegaly; Eosinophilia; Etoposide; Humans; Hydroxyurea; Male; Syndrome; Thrombocytopenia | 1991 |
Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Diarrhea; Drug Evaluation; Etoposide; Female; Floxuridine; Gastrointestinal Neoplasms; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Risk Factors; Stomatitis; Thrombocytopenia | 1991 |
Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Pilot Projects; Thrombocytopenia; Vomiting | 1991 |
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Hospitalization; Humans; Infant; Leukocyte Count; Male; Neutropenia; Neutrophils; Platelet Count; Recombinant Proteins; Thrombocytopenia | 1991 |
Chronic daily administration of oral etoposide in refractory lymphoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Thrombocytopenia | 1990 |
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Pilot Projects; Remission Induction; Survival Rate; Thrombocytopenia | 1990 |
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Remission Induction; Thrombocytopenia | 1990 |
Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma, Small Cell; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Thrombocytopenia | 1990 |
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Pilot Projects; Thrombocytopenia | 1990 |
Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Remission Induction; Survival Rate; Thrombocytopenia | 1990 |
Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Etoposide; Female; Gastrectomy; Humans; Male; Middle Aged; Neutropenia; Stomach Neoplasms; Thrombocytopenia | 1990 |
A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Drug Evaluation; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Remission Induction; Thrombocytopenia | 1990 |
Phase II trial of etoposide and doxorubicin in advanced head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Head and Neck Neoplasms; Humans; Inflammation; Leukocyte Count; Leukopenia; Mucous Membrane; Platelet Count; Remission Induction; Thrombocytopenia | 1990 |
Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pneumonia; Radiation Injuries; Remission Induction; Thrombocytopenia; Vincristine | 1989 |
[Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Pilot Projects; Remission Induction; Thrombocytopenia; Vincristine | 1989 |
[Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Pilot Projects; Remission Induction; Thrombocytopenia | 1989 |
[Combination therapy with etoposide, adriamycin and cisplatin in advanced primary and recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Remission Induction; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1989 |
Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Drug Evaluation; Etoposide; Humans; Leukopenia; Male; Mouth Mucosa; Neoplasms, Germ Cell and Embryonal; Stomatitis; Testicular Neoplasms; Thrombocytopenia | 1988 |
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Digestive System; Doxorubicin; Etoposide; Female; Humans; Kidney; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Vincristine | 1985 |
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Podophyllotoxin; Thrombocytopenia; Vincristine | 1985 |
Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
Topics: Actuarial Analysis; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vincristine | 1985 |
Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: tumor response and long term survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia | 1986 |
High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Fever; Humans; Infections; Leukopenia; Lung Neoplasms; Middle Aged; Thrombocytopenia | 1987 |
Phase I study of a carboplatin-etoposide combination in advanced thoracic cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Neutropenia; Organoplatinum Compounds; Pancytopenia; Thrombocytopenia | 1988 |
Etoposide for epidemic Kaposi's sarcoma: a phase II study.
Topics: Adult; Drug Evaluation; Etoposide; Humans; Leukopenia; Sarcoma, Kaposi; Thrombocytopenia | 1988 |
Intensive consolidation chemotherapy for acute lymphoblastic leukaemia (UKALL X pilot study).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Infections; Leukemia, Lymphoid; Male; Neutropenia; Pilot Projects; Thioguanine; Thrombocytopenia | 1987 |
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neutropenia; Recurrence; Thrombocytopenia | 1986 |
[A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
Topics: Adult; Aged; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Kinetics; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Thrombocytopenia | 1986 |
[ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
Topics: Aclarubicin; Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Naphthacenes; Prednisolone; Thrombocytopenia; Vincristine | 1986 |
[Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
Topics: Administration, Oral; Adult; Aged; Capsules; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia | 1985 |